Journal profile · Medicine-Ophthalmology
Frontiers in Ophthalmology
ISSN 2674-0826 · Frontiers Media S.A. · Switzerland
Frontiers in Ophthalmology: CAS Zone 4 · Medicine (2026 Xinrui edition); impact factor 2.4 (journal website); fully open access; APC charged, amount not published; median 67 days to acceptance (107 articles, last 24 months); 117 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Frontiers in Ophthalmology is published by Frontiers Media S.A. and is classed under Medicine in the CAS Journal Ranking. By OpenAlex counts of its recent articles, its largest topics are Glaucoma and retinal disorders, Retinal Diseases and Treatments and Ophthalmology and Visual Impairment Studies, together about 29.9% of its articles. Its main subfields are Ophthalmology and Radiology, Nuclear Medicine and Imaging. (generated from OpenAlex topic counts and CAS ranking data)
Frontiers in Ophthalmology is a multidisciplinary journal that focuses on advancing knowledge and understanding of eye diseases and disorders, as well as their diagnosis and management. Led by Field Chief Editor Andrew Lee from Houston Methodist Hospital, Frontiers in Ophthalmology welcomes research contributions in various domains of ophthalmology, optometry, and vision science, which bridge the gap between basic and clinical research. Frontiers in Ophthalmology is indexed in Web of Science Emerging Sources Citation Index (ESCI), PubMed Central (PMC) and Scopus, among others. Topics include, but are not limited to: corneal and ocular surface diseases disease mechanisms and etiologies glaucoma neuro-ophthalmology ocular inflammation ocular surgery pediatric ophthalmology randomized clinical trials real-life clinical studies retinal diseases therapeutic targets The journal supports the Sustainable Development Goal (SDG) 3: Good Health and Well-being by focusing on research and knowledge in ophthalmology, optometry, and vision science. This directly contributes to improving global health and well-being by addressing the challenges of vision impairment and eye diseases, which affect 2.2 billion people worldwide. Through a rigorous evaluation process and the publication of significant research, Frontiers in Ophthalmology supports the development of diagnostic and therapeutic tools, surgical innovations, and disease-tailored treatments. This aligns with SDG 3's target of ensuring healthy lives and promoting well-being for all at all ages. By fostering translational research and promoting ophthalmic clinical care worldwide, the journal contributes to the global effort to reduce the burden of vision impairment and improve overall health and well-being. Studies that primarily investigate mild ocular conditions, non-ophthalmic drug research, general microbiome research without a fundamental basis in eye health, and topics that are only tangentially related to the core principles of ophthalmology are not suitable for publication in this journal. Frontiers’ journals require that manuscripts primarily comprising computational studies of public data, must include appropriate validation. Please refer to the Frontiers Standards for research methodology policy, for more information. Manuscripts not adhering to these standards will not be considered. Frontiers in Ophthalmology is committed to advancing developments in the field of ophthalmology by allowing unrestricted acc
From the journal's Aims & Scope
Research area (LetPub): Medicine-Ophthalmology
Editorial board by country: 3 in mainland China (about 14%); most named United States 4, India 4, Singapore 4, Mainland China 3, United Kingdom 1 (21 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Glaucoma and retinal disordersMedicine12.4%
- Retinal Diseases and TreatmentsMedicine9.7%
- Ophthalmology and Visual Impairment StudiesMedicine7.7%
- Ocular Diseases and Behçet’s SyndromeMedicine6.7%
- Corneal surgery and disordersMedicine6.5%
- Retinal Development and DisordersBiochemistry, Genetics and Molecular Biology6.3%
- Intraocular Surgery and LensesMedicine5.7%
- Retinal and Macular SurgeryMedicine4.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Ophthalmology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of SciencePMCPublisher website
Other: EBSCO, ProQuest, Dimensions, CNKI, CLOCKSS, Crossref
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 2.4Publisher website ·
- CiteScore 2026-06
- 2.4LetPub ·
- CiteScore (publisher)
- 2.4Publisher website ·
- SJR 2026-06
- 0.62LetPub ·
- SNIP 2026-06
- 0.68LetPub ·
- h-index
- 19OpenAlex ·
- i10-index
- 67OpenAlex ·
- 2-year mean citedness
- 2.13OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 107LetPub ·
Articles by year OpenAlex count · 552 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 142 | 142 | 36 |
| 2025 | 117 | 117 | 195 |
| 2024 | 99 | 99 | 533 |
| 2023 | 115 | 115 | 689 |
| 2022 | 73 | 73 | 506 |
| 2021 | 6 | 6 | 29 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
67 daysMedian, submission to acceptance · P25–P75 47 days – 112 days
- Acceptance to online
- median 22 days (107 articles)
- Submission to online
- median 91 days
- Sample
- 107 articles with submission and acceptance dates (265 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 11 weeksLetPub ·
- Submission to publication (journal-reported)
- about 11 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | CHF 1,950 | Yes | CC BY | |
| OpenAlex | CHF 1,950 | — | — | |
| LetPub | USD 2,125 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Keywords
- 5–8
- Reference style
- Harvard
- Templates
- LaTeX and Word
Policy excerpts from the journal's websiteAI use, Conflicts of interest, License & copyright, Open access, Peer review
- AI use Use of AI to create written or visual content
Authors should not list a generative AI technology as a co-author or author of any submitted manuscript. Generative AI technologies cannot be held accountable for all aspects of a manuscript and consequently do not meet the criteria required for authorship. If the author of a submitted manuscript has used written or visual content produced by or edited using a generative AI technology, this use mu…
Source ↗Publisher website ·- Conflicts of interest Safeguards against financial conflicts of interest
Only leading researchers acting as Associate Editors, who are not part of Frontiers' staff, can make acceptance decisions based on reviews performed by external experts acting as Community Reviewers or Reviewers. None have a financial incentive to accept articles, i.e. they are not paid for their role as Associate Editor or community Reviewer, and any award scheme is not linked to acceptances of m…
Source ↗Publisher website ·- License & copyright Open access and copyright
All Frontiers' articles from July 2012 onwards are published with open access under the Creative Commons CC-BY license (the current version is CC-BY, version 4.0). This means that the author(s) retains copyright, but the content is free to download, distribute, and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article. Upon submission, the author(s)…
Source ↗Publisher website ·- Open access Open access and copyright
All Frontiers' articles from July 2012 onwards are published with open access under the Creative Commons CC-BY license (the current version is CC-BY, version 4.0). This means that the author(s) retains copyright, but the content is free to download, distribute, and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article. Upon submission, the author(s)…
Source ↗Publisher website ·- Peer review Peer review
Our rigorous, transparent peer review process combines expert review and constructive dialogue to strengthen your manuscript.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Frontiers Media S.A.
- Country or region
- Switzerland
- Language
- English
- ISSN
- 2674-0826
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Frontiers in Ophthalmology
What CAS zone is Frontiers in Ophthalmology in?
In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Frontiers in Ophthalmology?
The journal's website gives an impact factor of 2.4; this is the journal's own figure, as LetPub lists none for it; CiteScore 2.4, h-index 19.
How long does peer review take at Frontiers in Ophthalmology?
Based on the dates recorded on 107 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 67 days (interquartile range 47–112 days); authors report an average review time of about 11 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Frontiers in Ophthalmology?
According to the journal's author guidelines: Keywords: 5–8; Reference style: Harvard; Templates: LaTeX and Word. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Frontiers in Ophthalmology based?
Of the 21 board members whose country the journal's board page names, 3 (about 14%) are in mainland China; the countries named most often are United States (4), India (4) and Singapore (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Frontiers in Ophthalmology?
According to LetPub and DOAJ records, Frontiers in Ophthalmology is indexed in ESCI, Scopus and DOAJ. The journal's website also lists Web of Science and PMC; that list has not been checked against each database.
Is Frontiers in Ophthalmology open access, and what is the APC?
Frontiers in Ophthalmology is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .